The purpose of the activities carried out under this Regulation shall be to:
(a)
optimise the impact of existing interventions, services and commodities aimed at preventing and fighting the major communicable diseases affecting the poorest populations;
(b)
increase the affordability of key pharmaceuticals and diagnostics for the three diseases;
(c)
increase research and development, including vaccines, microbicides and innovative treatments.